Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase
Douglas C. Beshore(United States Military Academy), Theresa M. Williams(United States Military Academy), Michelle Ellis-Hutchings(United States Military Academy), Robert B. Lobell(United States Military Academy), Marc Abrams(Dicerna Pharmaceuticals (United States)), Nancy E. Kohl(United States Military Academy), George D. Hartman(Joint BioEnergy Institute), Samuel Graham(Georgia Institute of Technology), Joseph Culberson(United States Military Academy), Carl F. Homnick(United States Military Academy), Eileen S. Walsh(Janssen (Switzerland)), Hema Bhimnathwala(United States Military Academy), I‐Wu Chen(United States Military Academy), Carolyn A. Buser(United States Military Academy), Kenneth S. Koblan(Sumitomo Dainippon Pharma (United States)), Ian M. Bell(United States Military Academy), Joseph P. Davide(United States Military Academy), Debra A. McLoughlin(United States Military Academy), R. Robinson(United States Military Academy), Christopher J. Dinsmore(United States Military Academy), Hans A Huber(United States Military Academy), Christine Fernandes(United States Military Academy), Timothy Olah(Bristol-Myers Squibb (United States))
Cited by 5
Related Papers
Ultrawide‐Bandgap Semiconductors: Research Opportunities and Challenges
|Advanced Electronic Materials|2017|1.5k
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
|Cancer Immunology Research|2015|440
Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage
|Cancer Cell|2005|271
Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilones
|Proceedings of the National Academy of Sciences|1998|210